What's breaking now, across thousands of outlets.
(RTTNews) - Gilead Sciences, Inc. (GILD), a biopharmaceutical company, announced that it has reached an agreement to acquire investigational oral IL-23R inhibitor program, including lead asset HCXT-2001, from privately held PepStar Therapeutics Ltd.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
Nigerian Exchange Group (NGX Group) has called for a more integrated approach to capital formation across Africa, connecting businesses with appropriate sources of financing at every stage of their…
Treasury yields edged higher, having slid sharply on Thursday as investors sought safe havens from the turmoil in French government bonds.
TCS led the pack with a gain of 1.16% to ₹2,536, while Infosys added 0.21% to ₹1,155 and HCL Tech was nearly flat
European stocks fell for a second day as disappointing earnings, including from Kering SA’s Gucci, added to concerns over the artificial intelligence trade and elevated oil prices.
Key PointsCardano currently trades at a 93% discount to its all-time high from 2021.
